Methods

CF Sensing Ablation Catheter
The 7F quadripolar ablation catheter with a CF sensor (TactiCath, St. Jude Medical, Geneva, Switzerland) has a 3.5-mm tip electrode with 6 small irrigation holes (0.4 mm diameter) around the circumference, located 1.2 mm from the tip for saline irrigation during radiofrequency delivery (Figure 1 ). The ablation electrode contains a thermocouple to measure the electrode temperature.
The CF sensor consists of a deformable body (elastic polymer) and 3 optical fibers (0.125 mm diameter, Figure 1 ) attached circumferentially around the deformable body. Force on the deformable body changes the reflected wavelength of light in the 3 optical fibers. 8, 9, 11, 12 By monitoring the reflected wavelength, the system is able to calculate the amplitude and display the vector of the CF at 100 ms intervals.
Experimental Model
The experimental protocol was approved by the University of Oklahoma Committee on the Use and Care of Animals. Eight Figure 2 . Examples of measurements of electrogram parameters on a bipolar ventricular potential (top) and unipolar ventricular potential (bottom). Electrogram amplitude was measured from peak-to-peak. The mean negative dV/dt was measured as the amplitude of the downstroke divided by its duration. The amplitude of injury current was measured on the unfiltered unipolar electrogram from the baseline to the peak of ST elevation. mongrel dogs weighing 31 to 39 kg were anesthetized with sodium pentobarbital (30 mg/kg) and ventilated mechanically with room air. The right carotid artery was cannulated for monitoring arterial pressure. A 7F, 20-electrode catheter was inserted into the right jugular vein and advanced into the coronary sinus under fluoroscopic guidance. A 10F ultrasound catheter (AcuNav, Acuson) was inserted into the left femoral vein and advanced into the right atrium to be used for intracardiac echocardiography. Heparin (5000 IU) was administered intravenously, with additional doses, as necessary to maintain the activated clotting time >250 seconds. Transeptal puncture was performed under intracardiac echocardiography and fluoroscopic guidance. The CF ablation catheter was inserted into the left atrium through the transeptal sheath. The CF catheter was initially positioned centrally within the left atrium, without endocardial contact (confirmed by intracardiac echocardiography), to calibrate the CF sensor to 0 g (baseline noncontact value). The CF ablation catheter was advanced into the left ventricle (LV) for ablation. After LV ablation was complete, the transeptal sheath was withdrawn into the right atrium and the CF ablation catheter was positioned into the right ventricle (RV). Ablation was then performed in the RV as described below.
Ablation Protocol
Radiofrequency applications were performed at 3 separate sites in the LV (septum, lateral free-wall, and apical region) and 3 separate sites in the RV (basal free-wall, medial wall of the outflow tract, and apical region). These 6 locations were sufficiently far apart to identify accurately during lesion assessment. The 3 radiofrequency applications in the LV and the 3 radiofrequency applications in the RV were delivered at 3 different levels of CF (one each, randomized): (1) low CF (range 2-10 g, median 8 g);
(2) moderate CF (range 20-30 g, median 21 g); and (3) high CF (range 50-100 g, median 60 g, Figure 2 ). CF was stabilized and averaged over the 5 seconds before the onset of the radiofrequency application. Data for radiofrequency applications were not included if the catheter position or movement had changed during ablation or if the CF measured immediately after ablation had changed (>5-10 g). To examine selectively the effect of CF on lesion size, radiofrequency applications were delivered at constant radiofrequency power and application time. In the LV, radiofrequency applications were delivered at 40 Watts for 60 seconds, using a saline irrigation flow rate of 30 mL/min. Radiofrequency applications in the RV were delivered at 30 Watts for 60 seconds, using an irrigation flow rate of 17 mL/min. In the event of a steam pop (abrupt small increase of impedance, audible or not, confirmed by histology with small cavitation or crater formation) or impedance rise (>10 Ohms), the radiofrequency application was continued for the full 60 seconds to allow the comparison of lesion size. Lidocaine (100 mg) was administered intravenously just before ablation to prevent radiofrequency-induced ventricular fibrillation. Additional doses of lidocaine were administered as needed.
A custom radiofrequency generator (Radionics, model RFG-3DJ) was used to allow the recording of power, impedance, and electrode temperature at 20 ms intervals. Intracardiac electrograms (bipolar and unipolar signals), CF, radiofrequency power, impedance, and electrode temperature were monitored continuously and recorded (LabSystem Duo, CR Bard, Inc).
The dogs were euthanized 30 minutes after the final radiofrequency application. The hearts were excised and stained with triphenyl tetrazolium chloride, which stains intracellular dehydrogenase a deep red color, distinguishing viable (red), and necrotic (pale) tissue. The hearts were fixed in 10% formalin and sectioned to measure radiofrequency lesion size (maximum depth, maximum diameter, depth at the maximum diameter, and surface diameter). 
Measurement of Electrogram Parameters
Bipolar electrograms were recorded between the tip electrode and second electrode and filtered at 30 to 500 Hz. Unipolar electrograms were recorded between the tip electrode and a needle skin electrode, filtered at 1 to 500 Hz. The following electrogram measurements were obtained at each ablation site before the onset of the radiofrequency application: (1) bipolar ventricular potential amplitude (peak-to-peak); (2) bipolar ventricular potential mean negative dV/ dt (amplitude/duration, downstroke slope); (3) unipolar ventricular potential amplitude (peak-to-peak); (4) unipolar ventricular potential mean negative dV/dt (amplitude/duration, downstroke slope); and (5) unipolar injury current amplitude ( Figure 2 ).
Statistical Analysis
Statistical analyses were performed using SAS software (version 9.2). The relationships between average CF, peak electrode temperature, and decrease in impedance (the impedance at the onset of radiofrequency application minus the minimum impedance during the radiofrequency application) versus lesion depth and lesion diameter were assessed by a mixed effects model using Proc Genmod, providing β-coefficients for x variables and their corresponding 95% confidence intervals (CIs). Chi square test and Fisher exact test were used to test the overall association between CF category and the incidence of steam pop and impedance rise. The relationships between average CF, electrogram amplitude, mean negative dV/dt (downstroke slope), injury current amplitude, impedance at the onset of radiofrequency application, and impedance decrease were assessed by a mixed effects model using Proc Genmod. The relationship between the degree of impedance decrease and the occurrence of steam pop was assessed by Mann-Whitney U test. A probability value of <0.05 was considered to be statistically significant.
Results
Relationship Between CF and Lesion Size and Incidence of Steam Pop
A total of 48 lesions were created in the 8 dogs: 24 lesions in the RV (30 Watts, 60 seconds) at low CF (n=8), moderate CF (n=8), and high CF (n=8); and 24 lesions in the LV (40 Watts, 60 seconds) at low CF (n=8), moderate CF (n=8), and high CF (n=8). Lesion measurements were not used in the 4 transmural lesions observed in the RV (1 at moderate CF and 3 at high CF) because these values would be artificially low.
Lesion size was independent of the 3 locations in the RV and the 3 locations in the LV. At constant radiofrequency power and application time, lesion depth and diameter increased significantly with increasing CF (Figures 3 and 4 ). Lesions at lower power (30 Watts) and moderate CF were significantly deeper (6.7±0.8 mm versus 5.9±1.2 mm) and wider (9.6±1.1 mm versus 8.0±1.9 mm) than lesions at higher power (40 Watts) at low CF ( Figure 3C ). Lesions at lower power (30 Watts) and high CF were similar in depth and diameter to lesions at higher power (40 Watts) at moderate CF ( Figure 3C ). Lesion depth and diameter correlated well with average CF for both RV and LV. (Figure 4 ). Peak electrode temperature during the radiofrequency application correlated poorly with lesion depth and diameter ( Figure 5 ). The decrease in impedance during the radiofrequency application relatively correlated well with lesion depth and diameter for lesions in the LV: 95% CI=0.13-0.28 and 95% CI=0.20-0.33, respectively, and in the RV: 95% CI=0.03, 0.14 and 95% CI=0.06, 0.19, respectively, Figure 6A and 6B.
The incidence of a steam pop increased significantly with increasing CF at 40 Watts (P=0.03) and with higher power (40 Watts versus 30 Watts, P=0.02, Figure 7 ). At 30 Watts in the RV, a steam pop occurred during 0/8 radiofrequency applications at low CF, 1/8 radiofrequency applications at moderate CF, and 1/8 radiofrequency applications at high CF. At 40 Watts in the LV, a steam pop occurred during 0/8 radiofrequency applications at low CF, 4/8 radiofrequency applications at moderate CF, and 5/8 radiofrequency applications at high CF. An impedance rise (≥10 Ohms increase from the minimum value during radiofrequency) occurred only in 3/8 radiofrequency applications at high CF and high power (40 Watts). An impedance rise did not occur at lower CF or at 30 Watts.
Relationship Between Surrogate Parameters and CF and Lesion Size
The peak-to-peak amplitude and downstroke slope of the bipolar and unipolar ventricular potentials correlated poorly with CF ( Figure 8A-8D) . The amplitude of unipolar injury current correlated better with CF but still had a wide overlap in values ( Figure 8E ). The ratio of injury current/unipolar ventricular potential amplitude correlated less well with CF than injury current amplitude, Y=0.34+0.01*X, 95% CI=0.002-0.02, P=0.022 and Y=4.19+0.14*X, 95% CI=0.06-0.22, P=0.006, respectively. Impedance at the onset of radiofrequency application (initial impedance) also correlated poorly with CF ( Figure 8F ). The degree of decrease in impedance during the radiofrequency application correlated only slightly better with CF ( Figure 8G ). At higher radiofrequency power (40 Watts), the occurrence of a steam pop correlated with the degree of impedance decrease ( Figure 8H ), but there was no significant relationship between the time of steam pop and the degree of impedance decrease ( Figure 8I ).
Discussion
To our knowledge, this is a first study to examine the relationship between radiofrequency lesion size and CF in the beating heart. We found a wide range of lesion size (depth and diameter) for radiofrequency applications with varying CF but same power and application time. Under these conditions (constant radiofrequency power and time), lesion size correlated well with CF (Figures 3 and 4 ). Increasing from low CF to high CF increased lesion depth by 70% at 30 Watts and by 90% at 40 Watts (Figure 3C) . Lesions produced at 30 Watts and moderate CF were larger than lesions produced at 40 Watts and low CF, and lesions at 30 Watts and high CF were similar to lesions at 40 Watts and moderate CF (Figure 3) . These data indicate that increasing CF is comparable to increasing radiofrequency power.
By measuring CF before the onset of an radiofrequency application, an appropriate radiofrequency power and time can be selected to achieve efficacy (lesion depth) and minimize the risk of steam pop. Low CF may be compensated by delivering higher radiofrequency power. The incidence of steam pop may be decreased while maintaining similar radiofrequency lesion size by using lower radiofrequency power and maintaining good CF.
Peak electrode temperature during radiofrequency applications was not predictive of lesion depth or diameter ( Figure 5 ). The decrease in impedance during the radiofrequency application (initial impedance minus minimum impedance) correlated relatively well with lesion size (especially in the LV at 40 Watts, Figure 6 ). The degree of impedance decrease correlated with the occurrence of a steam pop at higher radiofrequency power (40 Watts) but did not correlate with the time of occurrence of the steam pop ( Figure 8H and 8I). One limitation of the impedance decrease is that this measure is not available before the onset of the radiofrequency application.
This study also demonstrates that the surrogate parameters of CF have limited or no value. Electrogram amplitude (unipolar and bipolar) and downstroke slope correlated poorly with CF. Even the amplitude of the injury current is a weak predictor of CF, although the presence of an injury current indicates some contact. Impedance is also not predictive of the magnitude of CF. These findings indicate the surrogate measures are poor predictors of CF and confirm the importance of directly measuring CF.
Study Limitation
A principal limitation of the study was that all radiofrequency applications were delivered for a relatively long interval (60 seconds). The impact of CF on lesion size may be even greater during shorter radiofrequency application times. The role of CF may also be greater or lesser at higher or lower radiofrequency power than the 30 Watts and 40 Watts used in this study. Further studies are required to compare the importance of CF to different radiofrequency power and application time.
Clinical Implications
Incorporating real-time CF measurement in an irrigated radiofrequency ablation catheter should help optimize the selection of radiofrequency power and application time to maximize radiofrequency lesion formation and reduce the risk of steam pop in clinical application.
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